Established in September 2015, located in Chongqing International Biological City, Chongqing Liujiang Pharma Technology Co., Ltd.
owns CRO platform for drug development, clinical phase I management and bioassay; in 2016, it was awarded “New Enterprise R&D Organization” by Chongqing Economic and Information Commission, and in 2017, it was approved by Chongqing Economic and Information Commission as the first generic drug quality and efficacy consistency evalsuation center in Chongqing.